Recovery · Research Phase
Matrikine Peptides
No lawful US pathway
01 · Overview
Matrikine peptides are bioactive fragments released from extracellular matrix proteins during tissue remodeling or injury. These sequences, derived from proteins such as collagen, elastin, fibronectin, and laminin, regulate cellular processes including migration, proliferation, and differentiation by binding to cell surface receptors.
Matrikines are thought to act as endogenous signals coordinating wound healing and tissue homeostasis.
02 · Research summary & key findings
Laboratory studies have identified matrikine sequences with distinct activities, such as the elastin-derived hexapeptide VGVAPG, which is chemotactic for monocytes (PMID 9266476), and the collagen-mimetic peptide DGEA, which supported mesenchymal stem cell adhesion, upregulated osteoblastic markers, and increased bone formation on coated implants in animals (PMID 19157536). Matrikine peptides have been used for decades in cosmetic skin products, and newer discovery methods continue to identify candidates for skin regeneration (PMID 41770626). Evidence is largely from cell and animal studies, and no matrikine has an approved pharmaceutical indication.
03 · Regulatory status
Matrikine Peptides is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.
No lawful pathway today
Matrikine Peptides is not FDA-approved and does not currently have a lawful prescription or compounding pathway in the United States, so we do not sell it and will not book a consultation for it. That can change: in 2026 FDA began reviewing several peptides for compounding. If you are working on the goal it is studied for, a licensed clinician can tell you what is lawfully available, which may be something else.
See the 3 FDA-approved compounds in Recovery
Tell me if the status changes
One email, only if this compound's regulatory standing actually moves. Not a newsletter, not a sales sequence.
Looking for a lawful, clinician-prescribed option for injury recovery and tissue repair?
Matrikine Peptides is a research compound, is not FDA-approved, and has no lawful US compounding pathway, so we do not offer it and no clinician we work with will prescribe it. Products sold online as “research chemicals” are not made or tested to the standards required of medicines. If you are working on injury recovery and tissue repair, a licensed clinician can tell you at a free consultation whether an FDA-approved or lawfully compounded treatment fits you, or whether nothing does.
Explore lawful options (free intake)About 3 minutes. If a protocol is prescribed through our provider, we earn 10% of the sale. See the receipts.
04 · Administration routes
- Topical
- Subcutaneous injection
References
- [1]The effect of collagen I mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfaces Biomaterials, 2009. PMID 19157536
- [2]Bioactive peptide matrikines: discovery approaches for skin rejuvenation Am J Physiol Cell Physiol, 2026. PMID 41770626
- [3]Structure-activity relationships for some elastin-derived peptide chemoattractants J Pept Res, 1997. PMID 9266476
Primary literature
- PubMed: "Matrikine Peptides"
Peer-reviewed literature indexed by the National Library of Medicine.
- ClinicalTrials.gov: "Matrikine Peptides"
Registered interventional and observational studies, including status and phase.
- PubChem: "Matrikine Peptides"
Chemical structure, molecular properties, and bioactivity data.
Related peptides in Recovery
Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed. Clinicians: join the network.